News

FDA may limit future Covid-19 shots to older people and those at risk of serious infection
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...
What the New COVID-19 Vaccine Guidance Means For You
Since 2023, federal health officials have recommended an annual COVID-19 shot for most people, and vaccine makers have not ...
Conspiracy Theorists Blame Covid-19 Vaccines for Joe Biden’s Cancer
Peter A. McCullough, a former cardiologist who promoted unproven treatments like ivermectin and hydroxychloroquine at the ...
FDA may limit future COVID-19 boosters to seniors, those at higher risk for complications
Top officials with the U.S. Food and Drug Administration are changing the agency's standards for updated COVID-19 booster ...
FDA Plans to Limit COVID-19 Vaccines to High-Risk Groups
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
Explore more
STAT15h
Five burning questions on the FDA’s new Covid-19 vaccine framework
But the framework has perhaps created as much confusion as clarity. Broadly, the FDA said it will limit approval of Covid-19 ...
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules
The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes. These risk ...